Anchalee Avihingsanon Selected Research

Coinfection

10/2022	Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.
1/2022	An alternative label-free DNA sensor based on the alternating-current electroluminescent device for simultaneous detection of human immunodeficiency virus and hepatitis C co-infection.
1/2022	A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
10/2021	Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.
1/2021	Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial.
1/2021	Incident Liver Cirrhosis, Associated Factors, and Cardiovascular Disease Risks Among People Living With HIV: A Longitudinal Study.
9/2020	Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm3 in Thailand.
1/2020	Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
1/2020	Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?
11/2017	Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anchalee Avihingsanon Research Topics

Disease

28	Coinfection 10/2022 - 01/2008
25	Infections 01/2022 - 04/2009
16	Tuberculosis (Tuberculoses) 06/2022 - 01/2008
13	HIV Infections (HIV Infection) 10/2021 - 03/2003
11	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 01/2011
10	Viremia 01/2022 - 04/2012
10	Fibrosis (Cirrhosis) 01/2022 - 09/2008
8	Hepatitis B 10/2022 - 09/2008
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 09/2008
6	Hepatitis C 01/2022 - 01/2012
5	Body Weight (Weight, Body) 07/2019 - 04/2012
5	Liver Diseases (Liver Disease) 01/2017 - 09/2008
4	Chronic Hepatitis B 06/2021 - 01/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
4	Chronic Renal Insufficiency 12/2020 - 09/2012
4	Lipodystrophy 01/2017 - 03/2003
3	Syphilis 01/2022 - 01/2020
3	Diabetes Mellitus 01/2021 - 01/2017
3	Hypertension (High Blood Pressure) 01/2021 - 04/2016
3	Opportunistic Infections (Opportunistic Infection) 09/2019 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2013
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2021 - 01/2019
2	Chronic Hepatitis C 05/2021 - 01/2021
2	Latent Tuberculosis 01/2021 - 03/2012
2	Drug-Related Side Effects and Adverse Reactions 09/2019 - 12/2013
2	Anemia 11/2018 - 01/2017
2	Insulin Resistance 01/2015 - 03/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Disease Progression 01/2022
1	Fatty Liver 01/2022
1	Frailty 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Weight Gain 01/2022
1	Dysbiosis 10/2021
1	Hepatitis 06/2021
1	Inflammation (Inflammations) 01/2021
1	Human Influenza (Influenza) 01/2020

Drug/Important Bio-Agent (IBA)

19	Pharmaceutical PreparationsIBA 01/2022 - 09/2008
15	Tenofovir (Viread)FDA Link 01/2021 - 04/2009
13	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2008
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2008
7	Ritonavir (Norvir)FDA Link 01/2021 - 10/2012
6	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2020
6	Hepatitis B e AntigensIBA 06/2021 - 09/2008
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 03/2007
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2022 - 01/2013
4	AntigensIBA 01/2022 - 08/2009
4	Alanine Transaminase (SGPT)IBA 01/2022 - 09/2008
4	InterferonsIBA 06/2021 - 09/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
3	Reverse Transcriptase InhibitorsIBA 01/2022 - 04/2009
3	grazoprevirIBA 10/2021 - 01/2020
3	elbasvirIBA 10/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2008
3	Lopinavir FDA Link 01/2021 - 01/2016
3	Emtricitabine (Emtriva)FDA Link 01/2021 - 01/2010
3	N-acetyltalosaminuronic acid (NAT)IBA 09/2020 - 01/2016
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2020 - 01/2008
2	CreatinineIBA 01/2022 - 04/2016
2	RacivirIBA 01/2021 - 01/2010
2	Stavudine (Zerit)FDA LinkGeneric 01/2021 - 03/2007
2	Lipopolysaccharide ReceptorsIBA 09/2020 - 09/2014
2	Hemoglobins (Hemoglobin)IBA 09/2020 - 07/2013
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 11/2009
2	efavirenz (Sustiva)FDA Link 01/2020 - 01/2016
2	EnzymesIBA 09/2019 - 09/2014
2	HDL CholesterolIBA 01/2019 - 01/2013
2	Raltegravir Potassium FDA Link 11/2017 - 04/2012
2	Atazanavir Sulfate (Reyataz)FDA Link 05/2015 - 12/2013
2	Nevirapine (Viramune)FDA Link 09/2014 - 01/2008
2	Vitamin D FDA LinkGeneric 09/2014 - 01/2014
2	Isoniazid (Ftivazide)FDA LinkGeneric 07/2012 - 03/2012
2	Lamivudine (Epivir)FDA Link 03/2012 - 01/2010
1	Surface Antigens (Surface Antigen)IBA 10/2022
1	IntegrasesIBA 01/2022
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2022
1	CalciumIBA 01/2022
1	Protons (Proton)IBA 01/2022
1	CytokinesIBA 06/2021
1	B-Cell Activating FactorIBA 06/2021
1	ravidasvirIBA 01/2021
1	N- (5- (1- methyl- 1H- pyrazol- 4- yl)- napthalene- 2- carbonyl)guanidineIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	tenofovir alafenamideIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	ProdrugsIBA 01/2021
1	dolutegravirIBA 01/2021
1	SofosbuvirIBA 01/2021
1	Anti-HIV Agents (AIDS Drugs)IBA 12/2020
1	Interleukin-7 (Interleukin 7)IBA 09/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2020
1	Oseltamivir (Tamiflu)FDA Link 01/2020
1	C-Reactive ProteinIBA 11/2019

Therapy/Procedure

30	Therapeutics 04/2022 - 03/2007
17	Art Therapy 10/2022 - 11/2009
12	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 03/2007
2	Polypharmacy 01/2022 - 01/2019
1	Renal Dialysis (Hemodialysis) 01/2022